The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 06, 2023
Filed:
Sep. 03, 2020
Applicant:
Sierra Oncology, Inc., Plymouth, MI (US);
Inventors:
Brandon H. Brown, Burlingame, CA (US);
Ernest A. Carra, Foster City, CA (US);
Jeffrey N. Hemenway, San Mateo, CA (US);
Henry Morrison, Dublin, CA (US);
Troy Reynolds, San Francisco, CA (US);
Bing Shi, Redwood City, CA (US);
Dimitrios Stefanidis, Mountain View, CA (US);
Fang Wang, Foster City, CA (US);
Matthew Robert Warr, Madison, CT (US);
James Andrew Whitney, Guilford, CT (US);
Yan Xin, San Carlos, CA (US);
Assignee:
Sierra Oncology, Inc., Plymouth, MI (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 239/42 (2005.12); A61K 31/535 (2005.12); A61K 31/5377 (2005.12); C07D 265/30 (2005.12);
U.S. Cl.
CPC ...
C07D 239/42 (2012.12); A61K 31/535 (2012.12); A61K 31/5377 (2012.12); C07D 265/30 (2012.12); C07B 2200/13 (2012.12);
Abstract
The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.